---
schema_version: "secwatch.filing_event.v1"
accession: "0001323885-24-000004"
form_type: "8-K"
ticker: "ATRC"
cik: "0001323885"
company_name: "AtriCure, Inc."
filed_at: "2024-01-04T23:59:59+00:00"
generated_at: "2026-06-07T03:52:06.552716+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# AtriCure appoints former J&J executive Shlomi Nachman to Board of Directors

## Summary
- Shlomi Nachman elected to AtriCure Board effective January 4, 2024.
- Nachman brings >25 years med device experience; was J&J Company Group Chairman for Cardiovascular and Specialty Solutions.
- He is an independent director per NASDAQ standards.
- He currently serves on boards of several private med device companies and the Beckman Foundation.
- CEO Michael Carrel says Nachman's experience in Afib market will be invaluable.

## SEC filing metadata
- accession: 0001323885-24-000004
- form_type: 8-K
- ticker: ATRC
- cik: 0001323885
- company_name: AtriCure, Inc.
- filed_at: 2024-01-04T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1323885/000132388524000004/0001323885-24-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1323885/000132388524000004/atrc-20240104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001323885-24-000004
- JSON: https://secwatch.observer/filing/0001323885-24-000004.json
- Plain text: https://secwatch.observer/filing/0001323885-24-000004.txt

## Key facts
- Executive change
  Shlomi Nachman was elected as director at AtriCure, Inc..
  - Action: elected
  - Role: director
  source text: elected Shlomi Nachman to serve as a director until the next Annual Meeting of Stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1323885/000132388524000004/0001323885-24-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.